Andrew S. Delemos
Expertise in
16
conditions

Dr. Andrew S. Delemos

Gastroenterology | Hepatology
1025 Morehead Medical Drive, Suite 600, 
Charlotte, NC 
Accepting New Patients
Offers Telehealth
Referral required
Before you request
Expertise in
16
conditions
1025 Morehead Medical Drive, Suite 600, 
Charlotte, NC 

Overview

Andrew Delemos is a Gastroenterologist and a Hepatologist practicing medicine in Charlotte, North Carolina.

Dr. Delemos is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Nonalcoholic Steatohepatitis (NASH), Visceromegaly, Hepatitis, Enlarged Liver, and Liver Transplant.

Dr. Delemos is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine, Transplant Hepatology, and American Board Of Internal Medicine, Gastroenterology. He is actively involved in clinical research, co-authoring 31 peer reviewed articles and participating in 5 clinical trials. Dr. Delemos is currently accepting new patients.

Specialties

Gastroenterology
Hepatology

Licenses

Internal Medicine in NC

Board Certifications

American Board Of Internal Medicine
American Board Of Internal Medicine, Transplant Hepatology
American Board Of Internal Medicine, Gastroenterology

Fellowships

Massachusetts General Hospital

Hospital Affiliations

Atrium Health Union
Atrium Health Lincoln
Atrium Health Cleveland
Atrium Health Pineville
Carolinas Medical Center/behav Health

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Absolute Total Care South Carolina
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
Aetna
  • EPO
  • HMO
  • POS
  • PPO
AmeriHealth
  • EPO
  • HMO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Sentara Healthcare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE ASSISTANCE PROGRAM
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 15 Less Insurance Carriers -

Locations

Transplant and Liver Center
1025 Morehead Medical Drive, Suite 600, Charlotte, NC 28204

Additional Areas of Focus

Dr. Delemos has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Autoimmune Hepatitis
Nonalcoholic Steatohepatitis (NASH)
Liver Transplant

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
Enrollment Status: Terminated
Publish Date: October 01, 2024
Intervention Type: Drug
Study Drug: Obeticholic Acid
Study Phase: Phase 3
A Phase 2, Prospective, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate Safety, Tolerability and Efficacy of Saroglitazar Magnesium in Patients With Primary Biliary Cholangitis (EPICS )
A Phase 2, Prospective, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate Safety, Tolerability and Efficacy of Saroglitazar Magnesium in Patients With Primary Biliary Cholangitis (EPICS )
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Drug
Study Phase: Phase 2
2017-01: Blood Sample Collection to Evaluate Biomarkers for Hepatocellular Carcinoma
2017-01: Blood Sample Collection to Evaluate Biomarkers for Hepatocellular Carcinoma
Enrollment Status: Completed
Publish Date: August 06, 2020
Intervention Type: Other
A Phase 2 Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate the Safety, Tolerability and Efficacy of Volixibat Potassium, an Apical Sodium-Dependent Bile Acid Transporter Inhibitor (ASBTi) in Adults With Nonalcoholic Steatohepatitis (NASH)
A Phase 2 Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate the Safety, Tolerability and Efficacy of Volixibat Potassium, an Apical Sodium-Dependent Bile Acid Transporter Inhibitor (ASBTi) in Adults With Nonalcoholic Steatohepatitis (NASH)
Enrollment Status: Terminated
Publish Date: November 25, 2019
Intervention Type: Drug
Study Phase: Phase 2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Emricasan, an Oral Caspase Inhibitor, in Subjects With Decompensated Non-Alcoholic Steatohepatitis (NASH) Cirrhosis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Emricasan, an Oral Caspase Inhibitor, in Subjects With Decompensated Non-Alcoholic Steatohepatitis (NASH) Cirrhosis
Enrollment Status: Unknown
Publish Date: March 19, 2019
Intervention Type: Drug
Study Drug: Emricasan
Study Phase: Phase 2
View 4 Less Clinical Trials

31 Total Publications

Modern Diets, Metabolic Inequity, and Race-Ethnic Disparities: Unraveling the Associations With MASLD and Cancer Risk.
Modern Diets, Metabolic Inequity, and Race-Ethnic Disparities: Unraveling the Associations With MASLD and Cancer Risk.
Journal: Journal of gastroenterology and hepatology
Published: August 08, 2025
Similar Doctors
Expertise in
19
conditions
Dr. Mark W. Russo
Gastroenterology | Hepatology
Expertise in
19
conditions
Dr. Mark W. Russo
Gastroenterology | Hepatology
Referral required
Before you request

Transplant And Liver Center

1025 Morehead Medical Drive, Suite 600, 
Charlotte, NC 
 (0.1 miles away)
704-355-6649
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Mark Russo is a Gastroenterologist and a Hepatologist practicing medicine in Charlotte, North Carolina. Dr. Russo is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Hepatitis, Visceromegaly, Cirrhosis, Liver Transplant, and Hepato-Pancreato-Biliary Surgery. Dr. Russo is board certified in American Board Of Internal Medicine, Gastroenterology. Dr. Russo is currently accepting new patients.

Expertise in
58
conditions
Dr. Fred C. Fowler
Gastroenterology | Hepatology
Expertise in
58
conditions
Dr. Fred C. Fowler
Gastroenterology | Hepatology
Referral may be required
Before you request

Carolina Digestive Health Associates PA

1085 Ne Gateway Ct Ne, Suite 280, 
Concord, NC 
 (22.1 miles away)
704-455-9700
Languages Spoken:
English, German, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Fred Fowler is a Gastroenterologist and a Hepatologist practicing medicine in Concord, North Carolina. Dr. Fowler is highly rated in 58 conditions, according to our data. His clinical expertise encompasses Lower Esophageal Ring, Benign Esophageal Stricture, Swallowing Difficulty, Gastrectomy, and Endoscopy. Dr. Fowler is board certified in American Board Of Internal Medicine, Gastroenterology. Dr. Fowler is currently accepting new patients.

Expertise in
69
conditions
Dr. Eric B. Thompson
Gastroenterology | Hepatology
Expertise in
69
conditions
Dr. Eric B. Thompson
Gastroenterology | Hepatology
Referral may be required
Before you request

Carolina Digestive Health Associates PA

1085 Ne Gateway Ct Ne, Suite 280, 
Concord, NC 
 (22.1 miles away)
704-455-9700
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Eric Thompson is a Gastroenterologist and a Hepatologist practicing medicine in Concord, North Carolina. Dr. Thompson is highly rated in 69 conditions, according to our data. His clinical expertise encompasses Hepatitis, Visceromegaly, Diverticular Disease, Gastrectomy, and Endoscopy. Dr. Thompson is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine, Transplant Hepatology, and American Board Of Internal Medicine, Gastroenterology. Dr. Thompson is currently accepting new patients.

Frequently Asked Questions about Dr. Andrew S. Delemos

How do I make an appointment with Dr. Andrew S. Delemos?

You can book an appointment with Dr. Andrew S. Delemos by calling their office at 704-355-6649. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Andrew S. Delemos a top-rated expert for Nonalcoholic Steatohepatitis (NASH)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Andrew S. Delemos is classified as an Distinguished expert for Nonalcoholic Steatohepatitis (NASH), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Andrew S. Delemos specialize in?

While Dr. Andrew S. Delemos is a Gastroenterology, they have specific expertise in Nonalcoholic Steatohepatitis (NASH), Visceromegaly, and Hepatitis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Gastroenterology.

Does Dr. Andrew S. Delemos participate in research or clinical trials?

Yes. Dr. Andrew S. Delemos has published 31 articles and abstracts on conditions like Nonalcoholic Steatohepatitis (NASH). You can view a list of Dr. Andrew S. Delemos's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Andrew S. Delemos accept my insurance?

Dr. Andrew S. Delemos accepts most major insurance plans, including Absolute Total Care South Carolina and Aetna. We recommend calling the office directly at 704-355-6649 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Delemos's expertise for a condition
ConditionClose
    View All 8 Distinguished Conditions
    View All 8 Advanced Conditions
    View All 22 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile